Phase II trial of Vitamin B6 for the HFS related to Capecitabine in adjuvant setting ( in Stage III colon cancer).
- Conditions
- Colon cancer
- Registration Number
- JPRN-UMIN000004171
- Lead Sponsor
- Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Not provided
1.Multiple cancer patient (within 5 years) 2.Severe infection or serious complications, such as hypoalimentation 3.Serious postoperative complications are not restored by registration 4. Have following complications I) Uncontrollable diabetes II) Uncontrollable hypertension III) The cirrhosis of the liver 5.Judged by the investigator to be unfit in the study for abnormality of the electrocardiogram, abnormal cardiac function having a history of serious heart trouble 6.Upper part digestive organs disorder or absorption disorder 7.Pregnancy, lactation woman, or woman with suspected pregnancy 8.Severe mental disease 9.Any subject judged by the investigator to be unfit for any reason to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method